Mexico - Delayed Quote • MXN Johnson & Johnson (JNJ.MX) Follow Compare 3,149.95 -20.05 (-0.63%) At close: January 31 at 2:12:12 PM CST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and T-Mobile US, Inc. (TMUS), as well as a micro-cap stock The Eastern Company (EML). US government could seek over $1 billion from J&J for cancer treatment costs The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that the company's baby powder and other talc products caused them to develop cancer, a government attorney said Friday. HHS and the Department of Veterans Affairs recently objected to J&J’s $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in bankruptcy could impair the government's reimbursement rights. Bethany Theriot, a U.S. Justice Department attorney representing the two agencies, said that HHS alone could seek $1.1 billion under the Medicare Secondary Payer law, which allows federal health agencies to seek reimbursement from other parties that are primarily responsible for health care costs incurred by the government. Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates Multinational healthcare company Johnson & Johnson (NYSE:JNJ) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 5.3% year on year to $22.52 billion. Its non-GAAP profit of $2.04 per share was 1.3% above analysts’ consensus estimates. Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with which the court largely agreed. Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025? We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to buy for the long term in 2025. The US stock market is often regarded as one […] Johnson & Johnson (JNJ): Is This Healthcare Stock A Good Buy? We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other healthcare stocks. Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential, and […] Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. Is Johnson & Johnson (JNJ) Among Kevin O’Leary’s Stock Picks for 2025? We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and entrepreneur, Kevin O’Leary, also known as ‘Mr. Wonderful’ is recognized mostly […] 4 robotic surgery trends to watch in 2025 Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems. Jim Cramer Explains Why Johnson & Johnson (JNJ) Might Be Unfairly Judged by the Market – Here’s Why We recently published a list of Jim Cramer Discusses These 13 Stocks & Rejects The AI PC Super Cycle. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against stocks that Jim Cramer discusses. In a fresh appearance on CNBC’s Squawk on the Street, Jim Cramer commented […] If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now? Johnson & Johnson (NYSE:JNJ) researches, develops, manufactures and sells various products in the health care field worldwide. It is set to report its Q1 2025 earnings on April 15. Wall Street analysts expect the company to post an EPS of $2.67, down ... Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. Why Johnson & Johnson (JNJ) Surged on Monday We recently compiled a list of the 10 Firms Post Impressive Gains on Monday. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note, with the Dow Jones the sole gainer, […] Jim Cramer Says You Should Buy Johnson & Johnson (JNJ) Dividend Stock With 3.3% Yield We recently published a list of Jim Cramer is Talking About These 10 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer is talking about. Jim Cramer in a latest program on CNBC discussed the reasons behind the recent market declines […] The Day DeepSeek Turned Tech and Wall Street Upside Down Monday’s bloodbath in Nvidia and other AI stocks wiped out some $1 trillion from the stock market’s value. Jim Cramer Says Johnson & Johnson (JNJ) is ‘Still Having A Problem With China’ We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer […] Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. Is Johnson & Johnson (JNJ) The Best Bear Market Stock To Invest In Now? We recently published a list of 11 Best Bear Market Stocks To Invest In Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best bear market stocks to invest in now. As of January 2025, the prevailing sentiment among US economic experts leans towards […] Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years? We recently published a list of 15 Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks ChatGPT predicts could make you wealthy in 10 years. 2024 was a stellar year for the US markets, […] These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024 The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. The DJIA itself gained 14% in 2024, far underperforming the larger and more diverse S&P 500, which gained 25%. In order of best to worst, the list includes Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), Amgen (NASDAQ: AMGN), Nike (NYSE: NKE), and Boeing (NYSE: BA). Performance Overview Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return JNJ.MX S&P 500 YTD +6.87% +2.26% 1-Year +15.88% +22.65% 3-Year -10.78% +36.30%